Intel (INTC) Lower Ahead of Q1 Report; PC Market, M&A Chatter Remain in Focus
Get Alerts INTC Hot Sheet
Price: $140.94 +5.19%
Revenue Growth %: +11.2%
Financial Fact:
Basic earnings per common share (in dollars per share): 0.71
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +11.2%
Financial Fact:
Basic earnings per common share (in dollars per share): 0.71
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Intel Corporation (Nasdaq: INTC) is trading in negative territory Tuesday ahead of the company's Q1 report, which is expected out after markets close.
Consensus estimates peg INTC posting Q1 EPS of $0.41 with revenue of $12.9 billion, from EPS of $0.38 and revenue of $12.8 billion reported in the same period last year.
Money flow on INTC is $30.0 million for an uptick-to-downtick ratio at 1.5 times, suggesting more buying pressure on the name in afternoon trading.
Cowen and company recently highlighted key issues for investors to watch into the report:
- PC market view in light of inventory/channel burn, potential demand destruction from FX and 2H impact from Win10;
- comments on improvement in MCG losses as this will become somewhat obfuscated by reporting combination w/PCG;
- gross margin impact from significant revenue decline in CQ1;
- update on Skylake timing (currently planned for late '15) and any further commentary on 10nm timing + implications on start-up costs;
- granularity on data center outlook given guide for 15% growth through 2018 and current mid 20's Y/Y growth; and
- potential color on foundry initiatives now that 14nm is ramping and potential Altera (Nasdaq: ALTR) M&A.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Intel (INTC) PT Raised to $135 at Mizuho
- Greenstone Biosciences, Inc. and Intel Corp. Launch Strategic Collaboration to Scale Human-Centric Drug Discovery
- Greenstone Biosciences and Intel team up on AI drug discovery
Create E-mail Alert Related Categories
Earnings, Trader TalkRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share